Helicobacter pylori Up-regulates Cyclooxygenase-2 mRNA Expression and Prostaglandin E2 Synthesis in MKN 28 Gastric Mucosal Cells in Vitro

This publication has 21 references indexed in Scilit:

• Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
  Journal of Clinical Investigation, 1998
• Expression of cyclooxygenase 1 (Cox-1) and 2 (Cox-2) in H. Pylori associated gastritis
  Gastroenterology, 1998
• Helicobacter pylori vacuolating toxin accumulates within the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity of ammonia
  The Journal of Pathology, 1997
• Aspirin use and potential mechanisms for colorectal cancer prevention.
  Journal of Clinical Investigation, 1997
• Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells
  Proceedings of the National Academy of Sciences, 1997
• cag , a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
  Proceedings of the National Academy of Sciences, 1996
• Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL‐8 in gastric epithelial cells
  Molecular Microbiology, 1995
• Eicosanoids and the gastrointestinal tract
  Gastroenterology, 1995
• Helicobacter pylori in Peptic Ulcer Disease
  JAMA, 1994
• Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia.
  Journal of Clinical Investigation, 1994